Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norspan for diabetic peripheral neuropathic pain
ACTRN12609000647235Phase 4Active, not recruiting
- Sponsor
- Mundipharma
- Start
- Mar 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised trial of buprenorphine in diabetic polyneuropathy (DPN) (2 arms), sponsored by Mundipharma. Primary endpoint: Proportion of subjects with at least 30% reduction in pain intensity. Started Mar 2010; status: active, not recruiting.
02
Drugs
buprenorphine
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on ACTRN12609000647235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000647235.